- home
- application
- Pharmaceutical
Pharmaceutical
In pharmaceutical production, consistency, purity, and regulatory compliance are non-negotiable.
applications
recent posts
speak to experts
we develop next-generation chemical reactor systems that harness the power of laminar Taylor flow
- +82-31-737-2375
- sales@laminarm.co.kr
APPLICATION OVERVIEW
Continuous, High-Purity Solutions for API and Fine Chemical Manufacturing
Lamina’s LCTR® (Laminar Continuous Taylor Reactor) offers a transformative solution for API synthesis, crystallization, purification, and particle engineering, enabling scalable continuous manufacturing with unmatched control. By minimizing batch-to-batch variation and enabling tighter control over temperature, residence time, and mixing efficiency, LCTR® systems allow pharmaceutical companies to meet GMP standards while optimizing cost and time.
Why LCTR® for Pharma?
- Enables high-purity output through precise control of crystallization and reaction conditions.
- Reduces processing time by integrating reaction, separation, and purification into a continuous flow.
- Delivers consistent results with uniform residence time and stable flow dynamics.
- Scales seamlessly from lab development to GMP-compliant industrial production.
- Minimizes solvent usage and waste, supporting greener pharmaceutical manufacturing.
- Aligns with global regulatory trends toward continuous manufacturing (FDA, EMA).
01. Drowning-out crystallization
- Objective: Time reduction, continuous
SMZ (Sulfameraine)
| CSTR | LCTR | |
| Production Time | 93 hours | 20 min |
02. Polymorphism
- Target : Amorphous → Crystal (cubic)
Enantiomer separation (Deracemization)
- Results: Decreased separation time (150 h → 12 h)
* ee: enantiomer excess value * These research results are excerpted from the work of Professor Woosik Kim of Kyung Hee University.


